Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
602
datasets available to search
ShareScore release 0.9.0
Dataset results
602 results for “natural killer cell”
Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02809092. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's Syndrome
ClinicalTrials.gov study NCT06967038. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
ClinicalTrials.gov study NCT04848064. IPD Sharing: NO. Countries: 1. Publications: 0.
Natural Killer (NK) Cell Therapy in Locally Advanced HCC
ClinicalTrials.gov study NCT05040438. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Implication of CCR4-NOT Complex Subunit 7 Expression in Natural Killer Cell Resistance in Metastatic Breast Cancer
ClinicalTrials.gov study NCT06320392. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors
ClinicalTrials.gov study NCT05887882. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT02185781. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Neonatal IgG Fc Receptor Expression in Natural Killer T Cells Expressing an Invariant T Receptor : Implication in the Pathophysiology of Systemic Lupus
ClinicalTrials.gov study NCT05859191. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant
ClinicalTrials.gov study NCT04836390. IPD Sharing: YES. Countries: 1. Publications: 0.
Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors
ClinicalTrials.gov study NCT02271711. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Killing Activity of Expanded Natural Killer Cells From Blood in Patients With Pancreatic Cancer
ClinicalTrials.gov study NCT03665571. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Pilot Study Immunomonitoring Natural Killers Cells in Patients With Myeloid Malignancies Treated With Lenalidomide
ClinicalTrials.gov study NCT02525250. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of MG4101 (Allogeneic Natural Killer Cell) for Intermediate-stage of Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02854839. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int
ClinicalTrials.gov study NCT03213964. IPD Sharing: Not stated. Countries: 1. Publications: 0.
2015-10: Expanded Natural Killer Cells and Elotuzumab for High-Risk Myeloma Post- Autologous Stem Cell Transplant (ASCT)
ClinicalTrials.gov study NCT03003728. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natural Killer Index From Hematopoietic Stem Cell Graft
ClinicalTrials.gov study NCT00435864. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cel
ClinicalTrials.gov study NCT02955550. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A First-in-human Study to Assess OT-C001 (Amplified/Activated Allogenic Natural Killer Cells) in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT07044050. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01478074. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
ClinicalTrials.gov study NCT02118285. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.